Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

SUMO modification of Huntingtin and Huntington's disease pathology.

Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, Illes K, Lukacsovich T, Zhu YZ, Cattaneo E, Pandolfi PP, Thompson LM, Marsh JL.

Science. 2004 Apr 2;304(5667):100-4.

2.

SUMO: a regulator of gene expression and genome integrity.

Müller S, Ledl A, Schmidt D.

Oncogene. 2004 Mar 15;23(11):1998-2008. Review.

PMID:
15021887
3.

SUMO promotes HDAC-mediated transcriptional repression.

Yang SH, Sharrocks AD.

Mol Cell. 2004 Feb 27;13(4):611-7.

4.

Nuclear and unclear functions of SUMO.

Seeler JS, Dejean A.

Nat Rev Mol Cell Biol. 2003 Sep;4(9):690-9. Review.

PMID:
14506472
5.

Solution structure of Vps27 UIM-ubiquitin complex important for endosomal sorting and receptor downregulation.

Swanson KA, Kang RS, Stamenova SD, Hicke L, Radhakrishnan I.

EMBO J. 2003 Sep 15;22(18):4597-606.

6.

Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.

Tatham MH, Kim S, Yu B, Jaffray E, Song J, Zheng J, Rodriguez MS, Hay RT, Chen Y.

Biochemistry. 2003 Aug 26;42(33):9959-69.

PMID:
12924945
7.

Solution structure of a CUE-ubiquitin complex reveals a conserved mode of ubiquitin binding.

Kang RS, Daniels CM, Francis SA, Shih SC, Salerno WJ, Hicke L, Radhakrishnan I.

Cell. 2003 May 30;113(5):621-30.

8.

P300 transcriptional repression is mediated by SUMO modification.

Girdwood D, Bumpass D, Vaughan OA, Thain A, Anderson LA, Snowden AW, Garcia-Wilson E, Perkins ND, Hay RT.

Mol Cell. 2003 Apr;11(4):1043-54.

9.

Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1.

Chauchereau A, Amazit L, Quesne M, Guiochon-Mantel A, Milgrom E.

J Biol Chem. 2003 Apr 4;278(14):12335-43. Epub 2003 Jan 14.

10.

The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1.

Kotaja N, Karvonen U, Jänne OA, Palvimo JJ.

J Biol Chem. 2002 Aug 16;277(33):30283-8. Epub 2002 Jun 11.

11.

Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in receptor endocytosis.

Shih SC, Katzmann DJ, Schnell JD, Sutanto M, Emr SD, Hicke L.

Nat Cell Biol. 2002 May;4(5):389-93.

PMID:
11988742
12.
13.

Identification of a substrate recognition site on Ubc9.

Lin D, Tatham MH, Yu B, Kim S, Hay RT, Chen Y.

J Biol Chem. 2002 Jun 14;277(24):21740-8. Epub 2002 Mar 4.

14.
15.

The nucleoporin RanBP2 has SUMO1 E3 ligase activity.

Pichler A, Gast A, Seeler JS, Dejean A, Melchior F.

Cell. 2002 Jan 11;108(1):109-20.

16.

PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.

Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R.

Genes Dev. 2001 Dec 1;15(23):3088-103.

17.

A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases.

Jackson PK.

Genes Dev. 2001 Dec 1;15(23):3053-8. Review. No abstract available.

18.

Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.

Saitoh H, Pizzi MD, Wang J.

J Biol Chem. 2002 Feb 15;277(7):4755-63. Epub 2001 Nov 14.

19.

Protein modification by SUMO.

Hay RT.

Trends Biochem Sci. 2001 May;26(5):332-3. No abstract available.

PMID:
11343927

Supplemental Content

Support Center